Contaminants and Natural Toxicants Subcommittee Meeting

Enterobacter sakazakii Contamination in Powdered Infant Formula

March 18-19, 2003

 

Tentative Agenda

 

March 18

 

8:00 8:30 Welcome, Introduction and Charges Christine J. Taylor, FDA

 

8:30 8:45 Administrative Issues - Jeanne Latham, FDA

 

8:45 9:15 Remarks by Chairpersons

 

9:15 3:45 Presentations by Guest Speakers

9:15 9:45 Tennessee outbreak investigation - Matthew Kuehnert, CDC

 

9:45 10:15 Other relevant investigations - Karl Klontz, FDA

 

10:15 10:30 Break

 

10:30 11:00 How individuals respond/Long term, chronic consequences John Alexander, FDA

 

11:00 11:30 Questions to speakers

 

11:30 12:30 Lunch

 

12:30 1:00 General Microbiology, e.g., ecology, pathogenicity, subtyping, etc.

Maria Nazarowec-White, Canada

 

1:00 1:30 Preliminary Subcommittee Discussion on Clinical Presentations

 

1:30 2:00 Microbial detection, clinical and food - Don Burr, FDA

 

2:00 2:30 Resistance Thermal and other - Robert Buchanan, FDA

 

2:30 2:45 Break

 

2:45 3:15 Manufacturing process, microbial standards, summary of FDA field survey - Don Zink, FDA

 

3:15 3:45 Current marketing and use of powdered infant formula - Sue Ann Anderson, FDA

 

3:45 4:00 Questions to speakers

 

4:00 5:00 Public Comment

 

5:00 6:00 Preliminary Discussion by Subcommittee

 

 

 

 

 

March 19

 

8:30 8:45 Opening Remarks

 

8:45 11:30 Subcommittee Discussion of Issues

 

10:00 - 10:15 Break

 

11:30 12:30 Lunch

 

12:30 3:00 Subcommittee Concluding Deliberations, Recommendations and Response to Charges